Germline inactivating TSC1, TSC2, DEPDC5 and NPRL3 variants are present in patients with FCD type II and HME, with second-hit brain-confined somatic mutations reported in some cases.9–11. Here, NPRL3 is linked to isolated focal cortical dysplasia type II.